Amrutanjan Health Care Ltd
Ticker: AMRUTANJAN
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
701.65
Market Cap
2027.77
Debt/Equity
0.0064
ROE %
16.527
PB
6.2085
Promoter %
46.516
Pledge %
0.000
1Y Rev Growth %
7.295
5Y Rev Growth %
11.717
NP Margin %
10.826
NP Margin 5Y Avg %
12.988
Trading Reference
1M Return %
-8.647
6M Return %
4.802
1Y Return %
-7.853
% Away 52W High
20.131
% Away 52W Low
28.956
Daily Volume
14236
Investment Verdict
Hold
Score 60/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 22/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Amrutanjan Health Care Ltd is currently trading near a key support level, with the 50-day EMA indicating bullish momentum. If the stock breaks above the resistance level, there is a potential for significant upside. However, if it falls below the support, downside risks increase.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
Y
Yasho Industries Ltd
Yasho Industries Ltd shows decent potential with consistent growth and a solid business model, but some risks and governance issues need to be monitored.
View details
S
Southern Petrochemical Industries Corporation Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dr Agarwal's Eye Hospital Ltd
Dr Agarwal's Eye Hospital Ltd shows potential for growth, but faces challenges in profitability and valuation metrics compared to peers.
View details
I
ICICI Prudential Nifty 50 ETF
The ICICI Prudential Nifty 50 ETF presents a decent investment opportunity with a diversified portfolio and consistent growth metrics, but investors should be cautious of market volatility.
View details
S
SG Finserve Ltd
SG Finserve Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
D
DCW Ltd
DCW Ltd shows potential in a stable sector but faces challenges in growth consistency and market sentiment.
View details
V
Veranda Learning Solutions Ltd
Veranda Learning Solutions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Precision Camshafts Ltd
Precision Camshafts Ltd shows potential but faces significant challenges in growth and profitability. Investors should be cautious.
View details
A
Apcotex Industries Ltd
Apcotex Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
S
Steelcast Ltd
Steelcast Ltd shows potential in a crucial sector with decent growth prospects, but faces challenges in profitability consistency and market sentiment.
View details
R
Rane Holdings Ltd
Rane Holdings Ltd presents a mixed investment case with decent fundamentals but notable risks in execution and market sentiment.
View details
I
India Nippon Electricals Ltd
India Nippon Electricals Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
M
MSP Steel & Power Ltd
MSP Steel & Power Ltd shows potential but faces significant challenges that could impact future performance.
View details
B
Bharat Global Developers Ltd
Bharat Global Developers Ltd has potential but faces challenges in growth consistency and profitability. Investors should proceed with caution.
View details
C
Cantabil Retail India Ltd
Cantabil Retail India Ltd shows potential but faces significant challenges in growth and profitability. Caution is advised.
View details
K
Kalyani Investment Company Ltd
Kalyani Investment Company Ltd presents several risks with limited growth prospects and inconsistent financial performance, making it a risky investment.
View details
Business Overview
Amrutanjan Health Care Ltd is a leading player in the Indian healthcare sector, specializing in pain relief and wellness products. With a legacy of over 125 years, the company focuses on providing effective solutions for everyday health issues, catering to a diverse consumer base. Its commitment to quality and innovation makes it a trusted choice for families across India.
- Established brand with over 125 years of experience
- Wide range of pain relief and wellness products
- Focus on quality and consumer satisfaction
- Innovative solutions for everyday health issues
- Strong distribution network across India
Investment Thesis
Amrutanjan Health Care Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's commitment to innovation and expanding market presence positions it well for future growth, making it a compelling investment opportunity.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services catering to evolving consumer needs.
- Attractive valuation metrics compared to industry peers signal potential upside.
- Established brand with a loyal customer base supports revenue stability.
- Strategic focus on innovation positions the company for sustainable growth.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong brand recognition
- Innovative product launches
- Increasing online sales channels
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
- Economic downturn impacts consumer spending
Peer Perspective
Amrutanjan Health Care Ltd trades at a discount to peers like Emami and Dabur, with a focus on improving margin stability; a sustained growth acceleration could trigger a rerating in its stock price.
Future Outlook
Amrutanjan Health Care Ltd is well-positioned for growth, driven by strong brand recognition and expanding product lines. Successful execution of its strategic initiatives and effective cost control will be crucial for maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Amrutanjan Health Care Ltd do?A: Amrutanjan Health Care Ltd manufactures health and wellness products, including pain relief and personal care items.
- Q: Is Amrutanjan a profitable company?A: Amrutanjan has shown profitability in recent years, but it's important to review financial statements for detailed insights.
- Q: What are the key risks of investing in Amrutanjan?A: Risks include market competition, regulatory changes, and dependency on consumer demand for health products.
- Q: How can I buy shares of Amrutanjan?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What should I consider before investing in Amrutanjan?A: Consider the company's financial health, market position, and your investment goals and risk tolerance.
📊 Stock Investment Checklist (100 Points)
Amrutanjan Health Care Ltd • Updated: 2025-09-17 01:11:46
-
10BusinessHighThe healthcare sector is growing, but competition is intense.
-
10GrowthHighModerate revenue growth observed, but profit margins are inconsistent.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is volatile.
-
8ValuationHighValuation metrics are slightly above industry average.
-
6BalanceGoodDebt levels are manageable, but liquidity could improve.
-
7GovernanceHighPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are high.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Amrutanjan Health Care Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 70/100